ClinicalTrials.Veeva

Menu

A Feasibility Study of Mindfulness Training Transcranial Direct Current Stimulation (tDCS) in Adults With Overweight and Obesity (MINDED)

K

King's College London

Status

Completed

Conditions

Adults With Overweight and Obesity

Treatments

Combination Product: Mindfulness training + real tDCS
Combination Product: Mindfulness training + sham tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT05865912
3159550

Details and patient eligibility

About

This study will investigate the feasibility of combining an app-based Mindfulness training (MT) with at-home administered transcranial direct current stimulation (tDCS) in adults with overweight or obesity and assess whether MT with tDCS may improve weight-related behaviours in this population. Specifically, the study will assess whether MT+ active tDCS, as opposed to MT+ sham tDCS or waiting list control, reduces high calorie food craving and consumption. Findings will inform the development of a future large-scale randomised controlled trial. The trial will be conducted in the UK.

Full description

A randomised controlled feasibility trial with three parallel arms: [MT + real tDCS] vs [MT + sham tDCS] vs [Waiting list control group].

Enrollment

52 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults aged 18 to 60 w
  • Overweight or obese (BMI ≥25 kg/ m2) according to World Health Organisation (WHO) criteria.
  • Use and understand English as a language for everyday conversation.
  • Have access to a laptop or desktop computer with webcam and to able to attend baseline, post intervention and follow up assessments in the Institute of Psychiatry, Psychology and Neuroscience (KCL).

Exclusion criteria

  • Insufficient written and spoken English
  • All known contraindications to tDCS (Brunoni et al., 2012)
  • Pregnancy; history of neurological disease and/or seizure
  • Having any metallic implants in the head or body
  • History of head or eye injury
  • Significant health problems in the previous six months
  • A lifetime diagnosis of substance dependence, psychosis, bipolar disorder, borderline personality disorder; any other primary psychiatric disorder requiring treatment in its own right
  • Taking psychotropic medication
  • Taking medication for weight loss Regular, current or past, mindfulness meditation or yoga practice (defined as > 20 minutes, twice or more per week during the past 2 months)
  • Consuming more than 14 units of alcohol per week who are unwilling to reduce their alcohol intake for the duration of the treatment
  • Current illicit drug use
  • Learning difficulties that would preclude safe tDCS self-administration and/or completion of questionnaire measures and neurocognitive tasks (e.g.; working memory and inhibitory control)
  • Current atypical anorexia nervosa or purging once a week or more.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

52 participants in 3 patient groups, including a placebo group

[Mindfulness training + real tDCS]
Experimental group
Treatment:
Combination Product: Mindfulness training + real tDCS
[Mindfulness training + sham tDCS]
Placebo Comparator group
Treatment:
Combination Product: Mindfulness training + sham tDCS
[Waiting list control group].
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems